Nick Devoogdt

Nick Devoogdt is a Professor in Molecular Imaging and Therapy at Vrije Universiteit Brussel. His work focuses on nanobody-based diagnostics and therapeutics, particularly in oncology, immunotherapy, and liver inflammation. He leads projects like CHOPIN (CD8+ T-cell imaging) and INTEGRAL (immunotherapy integration), with over 400 publications and 9 patents. Active in grants such as FWOAL1154 (radiotheranostics) and ANI395 (CAR-T engineering).

• Key Roles: Principal Investigator in 61+ projects, advisor for 57 student theses, and collaborator across 29+ institutions.
• Research Interests: Radiopharmaceutical development, antibody engineering, PET imaging, macrophage dynamics, and nanobody applications.

His team pioneered Nanobody tracers for immune monitoring (e.g., CD8β, CD163) and therapeutic nanobodies for liver injury. Notable awards include the Alavi-Mandell Award and multiple competitive grants. Media highlights include breakthroughs in affordable CAR-T therapy and liver inflammation treatments.

• Awards: Alavi-Mandell Award (2019), Best Poster Presentation (2024), and 7+ fellowships for innovative projects.
• Labs/Teams: Molecular Imaging & Therapy Lab, collaborations with Esobiotec (cell therapy startup), and global networks in nuclear medicine.